
    
      First, screening out patients who underwent hepatic tumor resection and pathologically
      diagnosed as HCC .

      Thenï¼Œperforming the detection of miR-145, miR-31 and miR-92a by using the HCC lymph node
      metastasis microRNA correlation prediction model established in our previous study. The
      patients are judged as high risk of lymph node metastasis and low risk Patients, then
      high-risk patients under the condition of informed consent into the group, randomized into
      treatment group and control groups.

      Last, Patients enrolled in the treatment group were treated with radiotherapy and followed
      up.
    
  